Emerging Pathways in COPD: Targeting Inflammation for A Tailored Treatment Approach
Explore the emerging pathways in COPD treatment by targeting inflammation for a tailored approach. Learn about the unmet needs in the COPD treatment landscape and the importance of personalized care for patients. Stay updated on the latest developments and expert opinions in COPD management.
Triple Inhaled Therapy Reduces Cardiopulmonary Risk in COPD Patients
Learn about the promising results of triple inhaled therapy with budesonide/glycopyrrolate/formoterol fumarate in reducing the risk of cardiopulmonary events in individuals with COPD. The post-hoc analysis based on the ETHOS phase 3 clinical trial showed a 20% reduction in risk compared to dual therapy, offering hope for improved outcomes and enhanced quality of life for COPD patients.
Higher Sedation Rates for Hispanic Patients on Ventilators May Impact Survival
Hispanic Americans on ventilators have a higher risk of death than white peers, possibly due to heavy sedation. Research from NYU and University of Michigan found that Hispanic patients in respiratory failure receive heavy sedation at a rate five times that of white patients, potentially lowering their odds for survival. The study suggests that language barriers, cultural differences, and hospital quality may be contributing factors.
Study Investigates Low Dose Morphine as Potential Treatment for Cough in Idiopathic Pulmonary Fibrosis Patients
A recent study, the PACIFY COUGH trial, has investigated the use of low dose controlled-release morphine as a potential treatment for cough in individuals with idiopathic pulmonary fibrosis (IPF). IPF is a progressive lung disease characterized by fibrosis, and cough…